Lōkahi Therapeutics™ Advances LT-100 Development Strategy Toward Single-Injection Administration
Go back to Lōkahi Therapeutics™ Advances LT-100 Development Strategy Toward Single-Injection Administration| (NASDAQ: GCTK) | Delayed: 2.30 +0.06 (2.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.24 | 52 Week High | $ | |||
| Open | $2.28 | 52 Week Low | $ | |||
| Day High | $2.30 | P/E | N/A | |||
| Day Low | $2.24 | EPS | $ | |||
| Volume | 9,643 | |||||

